Urbani Simona, Amadei Barbara, Cariani Elisabetta, Fisicaro Paola, Orlandini Alessandra, Missale Gabriele, Ferrari Carlo
Laboratory of Viral Immunopathology, Department of Infectious Diseases and Hepatology, Azienda Ospedaliera di Parma, Parma, Italy.
J Immunol. 2005 Dec 1;175(11):7519-29. doi: 10.4049/jimmunol.175.11.7519.
Evasion from protective CD8 responses by mutations within immunodominant epitopes represents a potential strategy of HCV persistence. To investigate the pathogenetic relevance of this mechanism, a careful search for immunodominant CD8 epitopes was conducted in six patients with chronic evolution of HCV infection by analyzing their global CD8 response with a panel of overlapping synthetic peptides covering the overall HCV sequence and by studying the CD8 frequency by tetramer staining. Immunodominant responses were followed longitudinally from the time of acute onset in relation to the evolution of the epitopic sequences. Although intensity of CD8 responses and frequency of HCV-specific CD8 cells declined over time in all patients, mutations emerged in only three of the six acute patients studied. Variant sequences were less efficiently recognized by CD8 cells than parental epitopes and were poorly efficient in inducing a CD8 response in vitro. CD8 epitopes undergoing mutations were targeted by high avidity CD8 cells more efficient in effector function. Our data support the view that immunodominant CD8 responses are affected by inhibitory mechanisms operating early after infection and that the emergence of escape mutations represents an additional mechanism of virus evasion from those CD8 responses that are functionally preserved.
免疫显性表位内的突变逃避保护性CD8反应是丙型肝炎病毒持续存在的一种潜在策略。为了研究这种机制的致病相关性,通过用一组覆盖整个丙型肝炎病毒序列的重叠合成肽分析其整体CD8反应,并通过四聚体染色研究CD8频率,对6例丙型肝炎病毒感染慢性进展患者进行了免疫显性CD8表位的仔细搜索。从急性发病时起,就表位序列的演变纵向跟踪免疫显性反应。尽管所有患者的CD8反应强度和丙型肝炎病毒特异性CD8细胞频率随时间下降,但在所研究的6例急性患者中只有3例出现了突变。与亲本表位相比,变异序列被CD8细胞识别的效率较低,并且在体外诱导CD8反应的效率也很低。发生突变的CD8表位被效应功能更有效的高亲和力CD8细胞靶向。我们的数据支持这样一种观点,即免疫显性CD8反应受感染后早期起作用的抑制机制影响,而逃逸突变的出现代表了病毒逃避那些功能上得以保留的CD8反应的另一种机制。